R

Replimune Group

Develops oncolytic viral immunotherapies for cancer

Senior Medical Director - Clinical Development

Biology & BiotechPosted on Nov 10
Full-timeWoburn, MA, USA

About the Job

Requirements

  • A medical degree (M.D.) is required.
  • Training and experience in oncology and immunotherapy are required.
  • At least 7 years of global clinical development experience and success within other biotechnology or pharmaceutical companies are required.
  • Professional knowledge and skills in solid-tumor oncology are required.
  • A high level of understanding of clinical development fundamentals is required, including protocol development and follow-up, study monitoring, data collection and analysis, database cleaning, and database lock.
  • Demonstrated experience designing development strategies, including the role of biomarkers, and leading Phase 1–3 programs is required, coupled with appropriate regulatory and commercial experience in successful oncology drug product approval and launch.
  • Knowledge of applicable international compliance guidelines and regulations, including FDA, EMA, and PMDA regulations and expectations, Good Clinical Practice, ICH guidelines, and clinical drug development, is required.
  • Experience representing the sponsor before regulatory agencies is required.
  • Knowledge of day-to-day medical monitoring of clinical trials is required, including responding to patient eligibility and protocol-waiver questions; reviewing safety parameters; working with Pharmacovigilance on SAE processing, including SAE narratives; and handling IND expedited safety reports.
  • Prior experience selecting and managing vendors is expected.
  • Experience developing and supporting related SOPs and policies is expected.
  • Experience with partnerships and strategic alliances is expected.
  • Proficiency with multiple computer-based tools, including Word, Project, PowerPoint, and Excel, is required.
  • Domestic and international travel of up to approximately 30% is required.

Responsibilities

  • Contribute to the overall clinical strategy for all or selected RP programs from early development through regulatory submissions and post-commercialization, with an emphasis on mid- to late-stage development.
  • Serve as Replimune’s clinical lead and point person on assigned programs and clinical trials from initiation to study discontinuation.
  • Lead or facilitate cross-functional clinical development and study teams, including designing studies in accordance with clinical strategy and driving preparation and approval of synopses and protocols and the conduct of clinical studies.
  • Ensure the medical science underpinning clinical studies is relevant and accurate through thorough scientific review and consultation with internal and external experts.
  • Organize and conduct consultations with global opinion leaders and contribute to or lead Advisory Board meetings.
  • Review and finalize the medical and scientific portions of clinical study concepts, protocols, and amendments.
  • Review and edit trial documents, including monitoring plans, statistical analysis plans, amendments, IRB/IEC submissions, and regulatory submissions.
  • Oversee cross-functional study teams and provide medical guidance to clinical study teams.
  • Conduct medical monitoring in partnership with CROs, Pharmacovigilance, biostatistics, clinical operations, and program leadership, including assessing study-conduct issues and individual-subject safety, identifying program, trial, or data risks, and creating and implementing mitigation strategies.
  • Maintain and develop relationships with key study investigators.
  • Provide medical input and guidance to development and study/project teams and collaborate with clinical operations, data management, other Medical Directors and Clinical Scientists, Pharmacovigilance, and Medical Affairs to deliver clinical trial data, assure data integrity, and consolidate information on trial progress.
  • Direct interpretation of clinical and translational study data; present findings to internal governance committees or management and help determine how study results affect overall compound strategy.
  • Author or contribute to clinical sections of communications and documentation for regulatory agencies, contribute to agency meetings, coordinate clinical documents and deliverables supporting regulatory filings, and provide input to regulatory questions.
  • Support clinical study reports, DSURs, PSURs, regulatory submission sections, and investigator brochures.
  • Ensure clinical activities and programs comply with GCP, regulatory requirements, and local and institutional requirements.
  • Work with Regulatory and cross-functional representatives to prepare high-quality documents for timely submission to the FDA and other health authorities, and represent Clinical at meetings with the FDA, EMEA, and other regulatory agencies.
  • Work with program management to integrate objectives, achieve milestones on schedule, and optimize resource use across functions.
  • Support tactical development of clinical trial programs, including prioritizing investigator-sponsored studies within the overall clinical strategy and conducting literature reviews.
  • Collaborate with Medical Affairs to develop medically accurate and appropriate educational materials for healthcare providers, patients, and other stakeholders.
  • Track competitors and clinical developments in relevant therapeutic areas by attending scientific meetings and reviewing literature.
  • Ensure consistent application of current scientific and ethical methods to design high-quality clinical investigational trials.
  • Help ensure clinical development activities are compliant, meet global industry standards, and stay within expected scope, budget, and timelines.
  • Collaborate with research and preclinical development colleagues to advance product candidates into clinical investigations.
  • Support business development by evaluating product candidates, determining product indications, and assisting with strategic planning and partnering discussions.
  • Complete and maintain compliance training, provide input on new initiatives, recommend compliance procedures, and assist in developing compliance and quality training materials.
  • Work with Commercial to develop commercialization strategy, including TPPs based on competitive assessment and target positioning; align clinical development strategy with commercial strategy and potentially design post-marketing studies.
  • Serve on internal committees as requested.
  • Represent Replimune on external committees and foundations as requested.
  • Assist with recruiting new employees, mentor junior team members, contribute to training materials, and guide new hires’ professional development.
  • Perform other duties as assigned.

Desired Qualifications

  • A PhD or additional science degree is desirable but not required.
  • Oncology board certification is preferred but not required.
  • Knowledge of requirements and processes for taking a drug candidate through clinical development to registration is preferred.
  • Experience in late-stage Medical Affairs and commercial environments, including planning and participating in pre-commercial activities for late-stage to commercial products, is preferred.
  • Familiarity with biostatistics principles used to analyze and interpret clinical-trial data is preferred.
  • Ability to interface effectively with key opinion leaders, investigators, CROs, and other entities is preferred.
  • Strong written and verbal scientific communication skills and analytical abilities are preferred.

About the Company

Replimune Group

Develops oncolytic viral immunotherapies for cancer

Replimune develops cancer therapies that use engineered viruses (oncolytic immunotherapies) to attack tumors. These treatments selectively infect cancer cells, causing their destruction, and at the same time stimulate the immune system to recognize and fight tumors. By combining multiple methods of action, Replimune aims to boost the effectiveness of existing immune checkpoint inhibitors and create a stronger anti-tumor response. The company focuses on research, development, and clinical testing, and plans to earn revenue through partnerships, licensing, and eventual sales of approved therapies. Its goal is to deliver workable cancer treatments by validating safety and efficacy in clinical trials and bringing these therapies to patients with various cancers.

Company size
201-500
Company stage
IPO
Headquarters
Woburn, MA
Founded
2015

Recently Posted Jobs

Explore more opportunities at Replimune Group

See more jobs